Management of idiopathic achalasia: drugs, balloon or knife?

Bibliography

• SPIESS AE, KAHRILAS PJ: Treating achalasia: from whalebone to laparoscope. JA/VIA (1998) 280:638–642.
   Google Scholar
• VAEZI ME RICHTER JE: Diagnosis and management of achalasia. ACG Practice guidelines. Am.! Gastroenterol. (1999) 38:1893–1904.
   Google Scholar
• ••A complete, comprehensive review of thediagnosis and treatment of achalasia.
   Google Scholar
• WONG RK, MAYDONOVITCH CL, METZ SJ, BAKER JR Jr: Significant DQw1 association in achalasia. Dig. Dis. Sci. (1989) 34:349–352.
   PubMed Web of Science ®Google Scholar
• VERNE GN, SALLUSTIO JE, EAKER EY: Anti-myenteric neuronal antibodies in patients with achalasia. A prospective study. Dig. Dis. Sci. (1997) 42:307–313.
   PubMed Web of Science ®Google Scholar
• STORCH WB, ECKARDT VF, JUNGINGER T: Complement components and terminal complement complex in oesophageal smooth muscle of patients with achalasia. Cell . Mol. Biol. (2002) 48:247–252.
   PubMed Web of Science ®Google Scholar
• MEARIN F, MOURELLE M, GUARNER F et al.: Patients with achalasia lack nitric oxide synthase in the gastro-esophageal junction. Eur . Clin. Invest. (1993) 23:724–728.
   PubMed Web of Science ®Google Scholar
• DE GIORGIO R, DI SIMONE MP, STANGHELLINI V, BARBARA G, TONINI M et al.: Oesophageal and gastric nitric oxide synthesizing innervation in primary achalasia. Am . .1. Gastroenterol. (1999) 94:2357–2362.
   Google Scholar
• •An elegant physiopathological study of achalasia.
   Google Scholar
• QUALMAN SJ, HAUPT HM, YANG P, HAMILTON SR: Oesophageal Lewy bodies associated with ganglion cell loss in achalasia: similarity to Parkinson's disease. Gastroenterology (1984) 87:848–856.
   PubMed Web of Science ®Google Scholar
• HOLLOWAY RH, DODDS WJ, HELM JF, HOGAN WJ, DENT J, ARNDORFER RC: Integrity of cholinergic innervation to the lower oesophageal sphincter in achalasia. Gastroenterology (1986) 90:924–929.
   PubMed Web of Science ®Google Scholar
• HIRANO I: Pathophysiology of achalasia. Carr. Gastroenterol. Rep. (1999) 1:198–202.
   PubMedGoogle Scholar
• HOLLAND CT, SATCHELL PM, FARROW BRH: Selective vagal afferent dysfunction in dogs with congenital idiopathic megaoesophagus. Auton . Neurosci. (2002) 99:18–23.
   PubMed Web of Science ®Google Scholar
• GOLDENBERG SP, BURRELL M, FETTE GG, VOS C, TRAUBE M: Classic and vigorous achalasia: a comparison of manometric, radiographic, and clinical findings. Gastroenterology (1991) 101:743–748.
   PubMed Web of Science ®Google Scholar
• BLAM ME, DELFYETTW, LEVINE MS, METZ DC, KATZKA DA: Achalasia: a disease of varied and subtle symptoms that do not correlate with radiographic findings. Am . J. Gastroenterol. (2002) 97:1916–1923.
   PubMed Web of Science ®Google Scholar
• KATZ PO, RICHTER JE, COWAN R, CASTELL DO: Apparent complete lower oesophageal sphincter relaxation in achalasia. Gastroenterology (1986) 90:978–983.
   PubMed Web of Science ®Google Scholar
• CAMPO SMA, TRAUBE M: Lower oesophageal sphincter dysfunction in diffuse oesophageal spasm. Am. J. Gastroenterol. (1989) 84:928–932.
   PubMed Web of Science ®Google Scholar
• HIRANO I, TATUM RP, SHI G, SANG Q, JOEHL RJ, KAHRILAS Manometric heterogeneity in patients with idiopathic achalasia. Gastroenterology (2001) 120:789–798.
   PubMed Web of Science ®Google Scholar
• •The heterogeneous findings in achalasia may reflect the various grades of impairment of myenteric plexus.
   Google Scholar
• LEMME EM, DOMINGUES GR, PEREIRA VL, FIRMAN CG, PANTOJA FJ: Lower oesophageal sphincter pressure in idiopathic achalasia and Chagas disease-related achalasia. Dis . Oesophagus (2001) 14:232–234.
   PubMed Web of Science ®Google Scholar
• GOYAL RK, HIRANO HM: Mechanisms of disease: the enteric nervous system. N. Engl. J. Med. (1996) 334:1106–1115.
   PubMed Web of Science ®Google Scholar
• •A comprehensive review of the importance of the enteric nervous system in the mechanisms of disease.
   Google Scholar
• HOWARD PJ, MAHER L, PRYDE A, CAMERON EWJ, HEADING RC: Five year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh. Gut (1992) 33:1011–1015.
   PubMed Web of Science ®Google Scholar
• WILLIS T: Pharmaceutice Rationalis Sive Diatribe de Medicametorum Operationibus in Human Corpore. London, England: Hagae Comitis (1674).
   Google Scholar
• WONG RK, GARCIA JE, JOHNSON LF, CASTELL DO: The effect of terbutaline sulfate, nitroglycerin, and aminophylline on lower oesophageal sphincter pressure and radionuclide oesophageal emptying in patients with achalasia. I Clin. Gastroenterol (1987) 9:386–389.
   PubMed Web of Science ®Google Scholar
• DI MARINO AJ, COHEN S: Effect of an oral I32-adrenergic agonist on lower oesophageal sphincter pressure in normal subjects and in patients with achalasia. Dis . Sci. (1982) 27:1063–1066.
   PubMed Web of Science ®Google Scholar
• GELFOND M, ROZEN P, KEREN S, GILAT T: Organic and fuctional disorders in 2000 gastroenterology outpatients. Gut (1981) 22:312–318.
   PubMed Web of Science ®Google Scholar
• WEN ZH, GARDENER E, WANG YP: Nitrates for achalasia. Cochrane Database Syst. Rev (2002) CD002299.
   Google Scholar
• TRAUBE M, HONGO M, MAGYAR L, MCCALLUM RW: Effects of nifedipine in achalasia and in patients with high-amplitude peristaltic oesophageal contractions. JA /VIA (1984) 252:1733–1736.
   PubMed Web of Science ®Google Scholar
• HONGO M, TRAUBE M, MCALLISTER RG, MCCALLUM RW: Effects of nifedipine on oesophageal motor function in humans: correlation with plasma nifedipine concentration. Gastroenterology (1984) 86:8–12.
   PubMed Web of Science ®Google Scholar
• VAN HARTEN J, BURGGRAAF K, DANHOF M, VAN BRUMMELEN P, BREIMER DD: Negligible sublingual adsorption of nifedipine. Lancet (1987) 2:1363–1365.
   PubMed Web of Science ®Google Scholar
• TRAUBE M, DUBOVIK S, LANGE RC, MCCALLUM RW: The role of nifedipine therapy in achalasia: results of a randomised, double-blind, placebo-controlled study. Am. J. Gastroenterol (1989) 84:1259–1262.
   PubMed Web of Science ®Google Scholar
• VAEZI ME RICHTER JE: Current therapies for achalasia: comparison and efficacy. J. Clin. Gastroenterol (1998) 27:21–35.
   PubMed Web of Science ®Google Scholar
• BORTOLOTTI M: Medical therapy of achalasia: a benefit reserved for few. Digestion (1999) 60:11–16.
   PubMed Web of Science ®Google Scholar
• TRIADOFILOPOULOS G, AARONSON M, SACKEL S, BURAKOFF R: Medical treatment of oesophageal achalasia: double-blind crossover study with oral nifedipine, verapamil, and placebo. Dig. Dis. Sci. (1991) 36:260–267.
   PubMed Web of Science ®Google Scholar
• BORTOLOTTI M, MARI C, LOPILETO C et al.: Effects of sildenafil on oesophageal motility of patients with idiopathic achalasia. Gastroenterology (2000) 118:253–257.
   PubMed Web of Science ®Google Scholar
• •A new way to treat achalasia, affecting NO-dependent neurotransmission.
   Google Scholar
• BORTOLOTTI M, MARI C, GIOVANNINI M et al.: Effects of sildenafil on oesophageal motility of normal subjects. Dig. Dis. Sci. (2001) 46:2301–2306.
   PubMed Web of Science ®Google Scholar
• RHEE PL, HYUN JG, LEE JH, KIM YH et al.: Effects of sildenafil on lower oesophageal sphincter and body motility in normal male adults. Am. Gastroenterol (2001) 96:3251–3257.
   PubMed Web of Science ®Google Scholar
• EHERER AJ, SCHWETZ I, HAMMER HF et al: Effects of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disorders. Gut (2002) 50:758–764.
   PubMed Web of Science ®Google Scholar
• NAIR LA, REYNOLDS JC, PARKMAN HP et al: Complications during pneumatic dilation for achalasia or diffuse oesophageal spasm: analysis of risk factors, early clinical characteristics, and outcome. Dig. as. Sci. (1993) 38:1893–1904.
   PubMed Web of Science ®Google Scholar
• GIDEON RIVI, CASTELL DO, YARZE J: Prospective randomised comparison of pneumatic dilatation technique in patients with idiopathic achalasia. Dig . Dis. Sci. (1999) 44:1853–1857.
   PubMed Web of Science ®Google Scholar
• ••A randomised study to compare differenttechniques of dilation in achalasia.
   Google Scholar
• SCHIANO TD, FISHER RS, PARKMAN HP et al.: Use of high resolution endoscopic ultrasonography to assess oesophageal wall damage after pneumatic dilation and botulinum toxin to treat achalasia. Castro. Enclose. (1996) 44:151–157.
   PubMed Web of Science ®Google Scholar
• PARKMAN HP, REYNOLDS JC, OUYANG A et al.: Pneumatic dilatation or esophagomyotomy treatment for idiopathic achalasia: clinical outcomes and cost analysis. Dig. Dis. Sci. (1993) 38:75–85.
   PubMed Web of Science ®Google Scholar
• SCHWARTZ HM, CAHOW CE, TRAUBE M: Outcome after perforation sustained during pneumatic dilatation for achalasia. Dig. Dis. Sci. (1993) 38:1409–1413.
   PubMed Web of Science ®Google Scholar
• •Description of the outcome of oesophageal perforation in patients with achalasia.
   Google Scholar
• MASSEY BT: Management of idiopathic achalasia: short-term and long-term outcomes. Curl-. Gastroenterol Rep. (2000) 2:196–200.
   PubMedGoogle Scholar
• ••An interesting study on the follow-up ofpatients with achalasia.
   Google Scholar
• TRAUBE M: The acid achalasia association. J. Clin. Gastroenterol (2002) 34:382–384.
   PubMed Web of Science ®Google Scholar
• •An editorial on the association between achalasia and reflux disease.
   Google Scholar
• CAMPO SMA, MORINI S, RE MA, LORENZETTI R, BOLOGNA E: Follow-up after pneumatic dilatation for achalasia. It.j Gastroenterol (1995) 27\(Supp1.1):265–266.
   Google Scholar
• PENAGINI R, CANTtJ P, MANGANO M, COLOMBO P, BIANCHI PA: Long -term effects of pneumatic dilatation on symptoms and lower oesophageal sphincter pressure in achalasia. Scanj GastroenteroL (2002) 37:380–384.
   PubMed Web of Science ®Google Scholar
• •Symptoms and LESP in the long-term follow-up of patients with achalasia after pneumatic dilation.
   Google Scholar
• SABHARWAL T, COWLING M, OWEN W, ADAM A: Balloon dilation for achalasia of the cardia: experience in 76 patients. Radiology (2002) 224:719–724.
   PubMed Web of Science ®Google Scholar
• DA SILVEIRA EB, ROGER Al: Achalasia: a review of therapeutic options and outcomes. Comp. The]: (2002) 28:15–22.
   PubMedGoogle Scholar
• CAMPO SMA, LORENZETTI R, DE MATTHAEIS M et al.: Achalasia: dilatazione pneumatica. Giorn. Ital. End. Dig. (2003) 26:59–63.
   Google Scholar
• PONCE J, GARRIQUES V, PERTEJO V, SALA T, BERENGUER J: Individual prediction of response to pneumatic dilation in patients with achalasia. Dig. Dis. Sci. (1996) 41:2135–2141.
   PubMed Web of Science ®Google Scholar
• KATZ PO, GILBERT J, CASTELL DO: Pneumatic dilatation is effective long-term treatment for achalasia.as. Sci. (1998)43: 1973-1977.
   Google Scholar
• BITTINGER M, WIENBECK M: Pneumatic dilation in achalasia. Can. J. Gastroenterol (2001) 15:195–199.
   PubMed Web of Science ®Google Scholar
• O'CONNOR JB, SINGER ME, IMPERIALE TF, VAEZI MF, RICHTER JE: The cost-effectiveness of treatment strategies for achalasia. Dig. Dis. Sci. (2002) 47:1516–1525.
   PubMed Web of Science ®Google Scholar
• ••Overview on cost-effective treatmentstrategies for achalasia.
   Google Scholar
• PASRICHA PJ, RAVICH WJ, HENDRIX TR, SOSTRE S, JONES B, KALLOO AN: Botulinum toxin for the treatment of achalasia. N Engl. J. Med. (1995) 322:774–778.
   Google Scholar
• ••The first report of botulinum toxin for thetreatment of achalasia.
   Google Scholar
• VAEZI ME, RICHTER JE, WILCOX CM et al: Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut (1999) 44:231–239.
   PubMed Web of Science ®Google Scholar
• •This review reports the importance of botulinum toxin and pneumatic dilation in patients with achalasia.
   Google Scholar
• ANNESE V, BASSOTTI G, COCCIA G et al: Achalasia Study Group. Comparison of two different formulations of botulinum toxin A for the treatment of oesophageal achalasia: a multicenter study. Aliment. PharmacoL Ther. (1999) 13(10):1347–1350.
   Google Scholar
• PANACCIONE R, GREGOR JC, REYNOLDS RP, PREIKSAITIS HG: Intrasphincteric botulinum toxin versus pneumatic dilatation for achalasia: a cost minimization analysis. Gastrointest. Enclose. (1999) 50:492–498.
   PubMed Web of Science ®Google Scholar
• GORDON JM, EAKER EY: Prospective study of oesophageal botulinum toxin injection in high-risk achalasia patients. Am. GastroenteroL (1997) 92:1812–1817.
   PubMed Web of Science ®Google Scholar
• ANDREWS CN, ANVARI M, DOBRANOWSKI J: Laparoscopic Heller's myotomy or botulinum toxin injection for management of oesophageal achalasia: patient choice and treatment outcomes. Surg. Endosc. (1999) 13:742–746.
   PubMed Web of Science ®Google Scholar
• BONAVINA L, INCARBONE R, ANTONIAZZI L et al: Previous endoscopic treatment does not affect complication rate and outcome of laparoscopic Heller myotomy and anterior fundoplication for oesophageal achalasia. Ital. J. GastroenteroL Hepatol (1999) 31:827–830.
   PubMedGoogle Scholar
• ANNESE V: Outpatient physiological testing and surgical management of foregut motor disorders. CLIFF. Pro& Surg. (1992) 24:415–455.
   Google Scholar
• ANDREWS CN, ANVARI M, DOBRANOWSKI J: Laparoscopic Heller's myotomy or botulinum toxin injection for management of oesophageal achalasia. Patient choice and treatment outcomes. Surg. Endosc. (1999) 13:742–746.
   Google Scholar
• FERGUSON MK, REEDER LB, OLAK J:Results of myotomy and partial fundoplication after pneumatic dilation for achalasia. Ann. Thome. Surg. (1996) 62:327–330.
   PubMed Web of Science ®Google Scholar
• ANCONA E, ANSELMINO M, ZANINOTTO G et al: Oesophageal achalasia: laparoscopic versus conventional open Heller-Dor operation. Am. J. Surg. (1995) 170:265–270.
   PubMed Web of Science ®Google Scholar
• VOGT D, CURET M, PITCHER D, JOSLOFF R, MILNE RL, ZUCKER K: Successful treatment of oesophageal achalasia with laparoscopic Heller myotomy and Toupet fundoplication. Am. j Surg. (1997) 174:709–714.
   PubMed Web of Science ®Google Scholar
• PATTI MG, PELLEGRINI CA, HORGAN S et al.: Minimally invasive surgery for achalasia: an 8-year experience with 168 patients. Ann. Surg. (1999) 230:587–593.
   PubMed Web of Science ®Google Scholar
• •New surgical option in the treatment of achalasia.
   Google Scholar
• ELLIS FH JR: Oesophagomyotomy for achalasia: a 22-year experience. Br. J. Surg. (1993) 80:882–885.
   PubMed Web of Science ®Google Scholar
• MATTIOLI S, DI SIMONE MP, BASSI F et al: Surgery for oesophageal achalasia: long-term results with three different techniques. Hepatogastroenterology (1996) 43:492–500.
   PubMedGoogle Scholar
• COSENTINI E, BERLAKOVICH G, ZACHERL J et al: Achalasia: results of myotomy and antireflux operation after failed dilatations. Arch. Surg. (1997) 132:143–147.
   PubMedGoogle Scholar
• KUMAR V, SHIMI SM, CUSCHIERI A: Does laparoscopic cardiomyotomy require an antireflux procedure? Endoscopy (1998) 30:8–11.
   PubMed Web of Science ®Google Scholar
• SHIINO Y, FILIPI CJ, AWAD ZT, TOM ONAGA T, MARSH RE: Surgery for achalasia. Gastrointest. Sorg. (1999) 3:447–455.
   PubMed Web of Science ®Google Scholar
• ••An overview of surgery for achalasia.
   Google Scholar
• PETERS JH, KAUER WK, CROOKES PF,IRELAND AP, BREMNER AP, DE MEESTER TR: Oesophageal resection with colon interposition for end-stage achalasia. Arch. Sorg. (1995) 130:632–637.
   PubMedGoogle Scholar
• BANBURY MK, RICE TW, GOLDBLUM JR et al.: Esophagectomy with gastric reconstruction for achalasia. Thorac. Cardiovasc. Sorg. (1999) 117:1077–1084.
   PubMed Web of Science ®Google Scholar
• MATHIAS CJ: Autonomic disorders and their recognition. N Engl. J. Med. (1997) 336:721–724.
   PubMed Web of Science ®Google Scholar
• CAMILLERI M: Neurogastroenterology: evolving concepts and tecniques to study motility and hypersensitivity. Digest. Liver Dis. (2000) 32\(Supp1.3):S227–S232.
   Google Scholar
• ••An overview of new concepts inneurogastroenterology.
   Google Scholar
• CAMPO SM, CAPRIA A, ANTONUCCI F et al: Decreased sympathetic inhibition in gastroesophageal reflux disease. Clin. Amon. Res. (2001) 11:45–51.
   Google Scholar
• BOWERY NG, PRATT GD: GABAB receptors as targets for drug action. Arzneimittel Forschung (1992) 42:215–223.
   PubMed Web of Science ®Google Scholar
• SANDERS KM, WARD SM: Nitric oxide as a mediator of non-adrenergic, non-cholinergic neurotransmission. Am. J. PhysioL (1995) 489:735–743.
   Google Scholar
• OLK W, KIESEWALTER B, AUER P, ENCK P et al: Extraesophageal autonomic dysfunction in patients with achalasia. Dis. Sci. (1999) 44:2088–2093.
   PubMed Web of Science ®Google Scholar
• •A study on the alteration of the autonomic nervous system in achalasia.
   Google Scholar
• RINALDI R, CORTELLI P, DI SIM ONE MP, PIERANGELI G et al: Cardiovascular autonomic function in patients with primary achalasia. Dis . Sci. (2000) 45:825–829.
   PubMed Web of Science ®Google Scholar
• •A study on the cardiovascular function in patients with achalasia.
   Google Scholar